Back
Amphastar Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
64
AMPH
Amphastar Pharmaceuticals
Last Price:
42.93
Seasonality Move:
16.67%
Sell
30
APLS
Apellis Pharmaceuticals
Last Price:
41.95
Seasonality Move:
-0.52%
Buy
64
Amphastar Pharmaceuticals (AMPH)
is a Buy
Is Amphastar Pharmaceuticals a Buy, Sell or Hold?
- The current Amphastar Pharmaceuticals [AMPH] share price is $42.80. The Score for AMPH is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- AMPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $43.90. The Score for APLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals's stock price today?
-
The Amphastar Pharmaceuticals share price today is $42.80
The current trend is relatively stagnant and AMPH is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $43.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 54.77 | Buy |
| Chaikin Money Flow: | 26657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.06 - 42.12) | Buy |
| Bollinger Bands (100): | (42.43 - 57.31) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.62 | Sell |
| Relative Strength Index (14 RSI): | 35.26 | Sell |
| Chaikin Money Flow: | -1199205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.44 - 54.24) | Sell |
| Bollinger Bands (100): | (52.49 - 66.65) | Sell |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.13 | Buy |
| 20-day SMA: | 41.01 | Buy |
| 50-day SMA: | 43.21 | Sell |
| 200-day SMA: | 50.99 | Sell |
| 8-day EMA: | 42.16 | Buy |
| 20-day EMA: | 41.82 | Buy |
| 50-day EMA: | 43.9 | Sell |
| 200-day EMA: | 47.83 | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.95 | Sell |
| 20-day SMA: | 49.03 | Sell |
| 50-day SMA: | 54.95 | Sell |
| 200-day SMA: | 51.22 | Sell |
| 8-day EMA: | 46.95 | Sell |
| 20-day EMA: | 49.15 | Sell |
| 50-day EMA: | 53.57 | Sell |
| 200-day EMA: | 56.71 | Sell |
Amphastar Pharmaceuticals Earnings Growth & AMPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.06 per share, an increase this year of $0.30 per share, and an increase next year of $0.55 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.56 per share, an increase this year of $3.59 per share, and an increase next year of $1.92 per share.
Amphastar Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||